FDA Inspection 730855 — Carter BloodCare - Longview
The FDA completed an inspection of Carter BloodCare - Longview on June 21, 2011 in Longview, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 21, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Longview, TX (United States)